COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 671
[34] Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue
transglutaminase as the autoantigen of celiac disease. Nat Med.
1997;3(7):797-801.
[35] Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of
front-line body defences. Nat Rev Immunol. 2003;3(1):63-72.
[36] Catanzaro JR, Strauss JD, Bielecka A, et al. IgA-deficient
humans exhibit gut microbiota dysbiosis despite secretion of
compensatory IgM. Sci Rep. 2019;9(1):13574.
[37] Fasano A. Intestinal permeability and its regulation by zonulin:
diagnostic and therapeutic implications. Clin Gastroenterol
Hepatol. 2012;10(10):1096-1100.
[38] Jolles S, Bernatowska E, de Gracia J, et al. Efficacy and safety
of Hizentra® in patients with primary immunodeficiency after a
dose-equivalent switch from intravenous or subcutaneous
replacement therapy: the SHIFT study. Orphanet J Rare Dis.
2011;6:61.
[39] Grimble RF. Nutritional modulation of immune function. Proc
Nutr Soc. 2001;60(3):389-397.
[40] Chapel H, Brennan V, Delson E. Immunoglobulin replacement
therapy by self-infusion at home. Clin Exp Immunol.
1988;73(1):160-162.
[41] Plotkin SA. Complex correlates of protection after
vaccination. Clin Infect Dis. 2013;56(10):1458-1465.
[42] Maecker HT, McCoy JP, Nussenblatt R. Standardizing
immunophenotyping for the Human Immunology Project. Nat Rev
Immunol. 2012;12(3):191-200.
[43] Kleiner G, Marcuzzi A, Zanin V, et al. Cytokine levels in the
serum of healthy subjects. Mediators Inflamm. 2013;2013:434010.
[44] Vreugdenhil GR, Geluk A, Ottenhoff TH, et al. Molecular
mechanisms underlying intestinal permeability changes:
671
